B A Chabner
- Oncology top 2%
- Cancer Treatment and Pharmacology 5
- Colorectal Cancer Treatments and Studies 4
- Toxicology top 2%
- Hematology top 5%
- Organic Chemistry top 5%
-
- Biochemical and Molecular Research 9
- Enzyme function and inhibition 5
- Cancer therapeutics and mechanisms 4
-
- Acute Lymphoblastic Leukemia research 7
-
- Chronic Lymphocytic Leukemia Research 4
-
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Michael R. GreverSaul A. SchepartzHerbert M. PinedoDario Livio LongoCarmen J. AllegraJ C DrakeJoseph R. BertinoJerry L. McCullough
- Cited by
- OncologyToxicologyHematology
- Journals
- Blood (7 papers)Journal of Clinical Oncology (5 papers)Journal of Biological Chemistry (2 papers)
- Partner nations
- United StatesMalaysiaUkraine
In The Last Decade
B A Chabner
44 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Oncology 1.1k
- Toxicology 109
- Hematology 269
- Pathology and Forensic Medicine 359
- Organic Chemistry 545
Countries citing papers authored by B A Chabner
This map shows the geographic impact of B A Chabner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B A Chabner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B A Chabner more than expected).
Fields of papers citing papers by B A Chabner
This network shows the impact of papers produced by B A Chabner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B A Chabner. The network helps show where B A Chabner may publish in the future.
Co-authorship network
The 25 scholars most cited alongside B A Chabner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 79 | |
| 2 | 1994 | 346 | |
| 3 | 1991 | 60 | |
| 4 | 1989 | 34 | |
| 5 | Cancer chemotherapy and biological response modifiers annual | 1987 | 221 |
| 6 | Preliminary results of a phase II trial for the treatment of metastatic breast cancer with 5-fluorouracil and leucovorin. | 1987 | 12 |
| 7 | ヒトMCF‐7乳がん細胞における細胞内葉酸プールに対するメトトレキセートの影響 プリン合成の直接阻害の証拠 | 1986 | 1 |
| 8 | Potential roles for preclinical pharmacology in phase I clinical trials. | 1986 | 155 |
| 9 | The cancer pharmacology annual | 1984 | 7 |
| 10 | 1984 | 11 | |
| 11 | 1982 | 16 | |
| 12 | 1980 | 55 | |
| 13 | Potential clinical applications of a new method for quantitation of plasma levels of 5-fluorouracil and 5-fluorodeoxyuridine. | 1979 | 5 |
| 14 | Role of drug concentration, duration of exposure, and endogenous metabolites in determining methotrexate cytotoxicity. | 1977 | 64 |
| 15 | Dose-dependent metabolism of methotrexate in man and rhesus monkeys. | 1977 | 45 |
| 16 | 1976 | 11 | |
| 17 | 1976 | 2 | |
| 18 | 1976 | 56 | |
| 19 | 1975 | 74 | |
| 20 | 1971 | 39 |
About B A Chabner
B A Chabner is a scholar working on Oncology, Hematology, Genetics, Pathology and Forensic Medicine and Molecular Biology, having authored 46 papers that have together received 2.8k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (9 papers), Acute Lymphoblastic Leukemia research (7 papers), Enzyme function and inhibition (5 papers), Cancer Treatment and Pharmacology (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Cancer therapeutics and mechanisms (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). The work is most often cited by research in Oncology (1.1k citations), Toxicology (109 citations), Hematology (269 citations), Pathology and Forensic Medicine (359 citations) and Organic Chemistry (545 citations). B A Chabner has collaborated with scholars based in United States, Malaysia and Ukraine. Frequent co-authors include Michael R. Grever, Saul A. Schepartz, Herbert M. Pinedo, Dario Livio Longo, Carmen J. Allegra, J C Drake, Joseph R. Bertino, Jerry L. McCullough, Jacques Jolivet and Bernard Fisher. Their work appears in journals such as Blood, Journal of Clinical Oncology, Journal of Biological Chemistry, Annals of the New York Academy of Sciences and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.